American Cancer Society Request for Applications (RFA): The Role of Healthcare and Insurance in Improving Outcomes in Cancer Prevention, Early Detection and Treatment

Application deadline (electronic and paper): October 15th, 2008

The American Cancer Society is announcing this RFA to investigate the impact of healthcare costs, healthcare system and capacity, insurance status, social factors and delivery of health care services, on outcomes in cancer prevention, early detection and treatment. The purpose of this RFA is to stimulate research on the effects of the US healthcare system structure and the role of insurance on access to screenings and treatment. Of particular interest is research using linked databases such as SEER, Medicare payment data, State data and NCHS data; other existing databases. Studies may be at the state, multi-state, or national levels, or otherwise involve large populations. Respondents should specifically describe how their results would generalize to the broader corresponding U.S. populations.

Three areas of investigation will receive special consideration:

1. How does the structure and capacity of the healthcare system affect appropriate and timely access to cancer screening, early detection, treatment and palliative care?
2. What provider and system factors affect treatment patterns and quality of cancer care within the current healthcare systems?
3. Explore life course patterns of the entire spectrum of cancer care (from prevention and screening through diagnosis, treatment, survivorship, and supportive/palliative care) by linking diverse data sources for broad patient populations.

Eligibility: Independent investigators at all stages of their career are eligible to apply. Thus, the usual ACS restriction to investigators within the first six years of their initial independent research appointment does not apply to this RFA.
Length of Study: Awards may not exceed a period of 4 years, although it is anticipated that most applications will require no more than two years to complete the research.
Budget: Awards may not exceed $200,000 per year (direct costs) plus 20% indirect costs.
Awards: It is anticipated that a total of $1,000,000 per year will be available for 4 to 6 applications selected through the Society's peer review system.
Deadlines: There are two deadlines for receipt of applications per year as for all other ACS applications. The next one is October 15th, 2008.

Applications must be submitted both electronically and with a paper copy as per guidelines on http://www.cancer.org. For additional information not covered on this announcement, please contact Dr. Ronit Elk by email only: Ronit.Elk@cancer.org

American Health Assistance Foundation Accepting Applications for Alzheimer's Disease Research

Program Deadline: October 22, 2008

Since its Alzheimer's Disease Research program began in 1985, the American Health Assistance Foundation has awarded more than $60 million to support promising research in fields ranging from molecular biology to epidemiology.

Grants are awarded on the basis of the scientific merit of the proposed research and the relevance of the research to understanding aspects of the disease that lead to improved treatments, prevention strategies, and diagnoses.

The program offers three types of awards: Standard Grants of up to a maximum of $400,000 over three years; Pilot Awards of up to a maximum of $150,000 over two years; and Research Fellowships of up to a maximum of $100,000 over two years.

In order to be eligible for the ADR Programs Standard and Pilot Grants, the principal investigator must be an independent researcher at a nonprofit research institution and hold an equivalent to the academic rank of assistant professor or higher. The Program's Research Fellowships are available to junior and senior postdoctoral fellows. Applicants must be associated with a nonprofit institution. AHAF funds internationally and does not require that applicants have U.S. citizenship.

For complete application guidelines go to http://www.ahaf.org/alzdis/research/
grants.htm

Doris Duke Charitable Foundation (DDCF) Clinical Scientist Development Award Program 2009

RESPONSE NEEDED BY Monday, October 27, 2008

The Doris Duke Clinical Scientist Development Award Program supports junior faculty with an M.D. or M.D. /Ph.D. (physician-scientists) early in their careers as independent clinical researchers. During this critical period, it is often more difficult for junior physician-scientists to transition from working in a mentor's laboratory to setting up an independent research program because they have to balance the demands of seeing patients with conducting research. This program can assist physician-scientists to make the conversion from trainees to independent clinical investigators. Junior-level faculty working in any disease area will be considered. The Foundation strongly encourages women and under-represented minorities in medicine to apply for this award. The award provides $135,000 per year for 3 years.

Full program information and specific requirements can be obtained on the DDCF website located at: http://www.ddcf.org/mrp-csda.

Hopkins may submit three nominations for this special award program, and the internal peer review to select nominees will be managed through the Provost's Office.

Required materials for internal review:

1. JHU Internal Submission Cover Sheet (contact Paul Smith for a copy at psmith17@jhu.edu)
2. Research plan (4-5 pages, not including figures and references)
3. Curriculum Vitae (2-4 pages, listing all funding sources)
4. A letter of recommendation from the candidate's department chair/director

Interested candidates should submit a complete packet of materials for internal review no later than 5 p.m. on Monday, October 27, 2008, via email, to psmith17@jhu.edu. This ensures that the internal selection can be completed in a timely fashion and the final proposals can be submitted to the DDCF by the December 17, 2008 deadline. If you have any questions, please contact me.

Funding for Prostate Cancer Research

DEADLINE: Monday, January 5, 2009

Funding is available to support multidisciplinary research in prostate cancer through the Patrick C. Walsh Prostate Cancer Research Fund. Awards of a maximum of $75,000 for up to two years are available to fund career development and developmental research programs (pilot projects). New Ideas Encouraged!

For more information, visit the website at: http://prostatecancerprogram.onc.jhmi.edu/

The McKnight Endowment Fund for Neuroscience 2009 McKnight Scholar Awards

Application deadline January 2, 2009

The McKnight Scholar Awards encourage neuroscientists in the early stages of their careers to focus on disorders of learning and memory. The awards support young scientists who hold the M.D. and/or Ph.D. degree, who have completed formal postdoctoral training, and who demonstrate a commitment to neuroscience. The Endowment Fund especially seeks applicants working on problems that, if solved at the basic level, would have immediate and significant impact on clinically relevant issues. Each year, up to six scholars are selected to receive three years' support. Currently, awards are $75,000 per year. Funds may be used in any way that will facilitate development of the Scholar's research program, but not for indirect costs. For complete details on this program, including eligibility requirements and application instructions, click here: http://www.mcknight.org/neuroscience/awards/scholar.aspx

NIH Roadmap Transformative R01 Program (R01)

Application Deadline January 29, 2009 (Letter of Intent due date December 29, 2008).

The NIH solicits applications from institutions/organizations proposing exceptionally innovative, high risk, original and/or unconventional research with the potential to create new or challenge existing scientific paradigms. Projects must clearly demonstrate potential to produce a major impact in a broad area of biomedical or behavioral research. Projects in any area of NIH interest that meet the transformative criteria above are encouraged and will be considered responsive to this FOA.

Areas of highlighted need that have been identified through an NIH strategic planning process include:

• Understanding and facilitating behavior change
• Formulation of novel protein capture reagents
• Functional variation in mitochondria in disease
• Complex 3-Dimensional tissue models
• Transitions from acute to chronic pain
• Providing an evidence base for pharmacogenomics

The NIH common fund intends to commit $25 million dollars in FY 2009 to fund up to 60 applications submitted in response to this FOA. Budget requests should be commensurate with project needs up to a five-year project period. There is no budget limit per proposal up to the budget cap for the program as a whole. To read the complete announcement and application instructions, click here: http://grants.nih.gov/
grants/guide/rfa-files/RFA-RM-08-029.html

Return to top of Funding Opportunities